52B-89600-31844
2 vaccinations
3 coded responses
18 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 033 / NH
- Registered
- 2021-12-01
- Relationship
- Child or adolescent in my care
- Guardian
- 3EP-11034-84999
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-22
Dose 1 — Pfizer-BioNTech
-
2021-12-01
Registered in v-safe
- 2021-12-01
- 2021-12-06
- 2021-12-13
-
2021-12-14
Dose 2 — Pfizer-BioNTech
-
2021-12-15
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-12-16
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-17
- 2021-12-18
- 2021-12-19
- 2021-12-20
- 2021-12-23
- 2021-12-29
- 2022-01-06
-
2022-01-11
Survey response — day 28, dose 2, dependentMedDRA: Headache, Lymphadenopathy, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Headache, swollen lymph nodes, fever. COVID negative x2, symptoms now resolved.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-18
- 2022-01-25
- 2022-03-15
-
2022-06-14
Survey response — 6 months, dose 2, dependentMedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Survey response — 12 months, dose 2, dependentMedDRA: Gastrointestinal viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: GI bugMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-22 | Pfizer-BioNTech | No |
| 2 | 2021-12-14 | Pfizer-BioNTech | No |
Free text
Release 10 — day 28, dose 2, dependent
Symptoms: Headache, swollen lymph nodes, fever. COVID negative x2, symptoms now resolved.
Release 12 — 6 months, dose 2, dependent
Symptoms: COVID-19
Release 12 — 12 months, dose 2, dependent
Symptoms: GI bug
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gastrointestinal viral infection | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release